454 GS Junior Drives 1 Percent Growth in Roche's Sequencing, Array Business in Q1
April 19, 2011
454 GS Junior Drives 1 Percent Growth in Roche's Sequencing, Array Business in Q1
"We are pleased with the rapid adoption of the GS Junior System in the market," a 454 Life Sciences spokesperson told In Sequence. "We have placed hundreds of GS Junior instruments in laboratories worldwide."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- For 454 Technology, Roche Bets on Specific Apps, Taking Share from Sanger
August 10, 2010 / In Sequence - Roche and Spanish Collaborators to use 454 to Study Hepatitis Drug Resistance
April 12, 2011 / Clinical Sequencing News - Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays
October 19, 2010 / In Sequence - NuGen, Roche's 454 Team to Provide Sample Prep for Low-Abundance RNA Sequencing
April 7, 2011 / PCR Insider - Roche's Sequencing Business Grows 12 Percent YTD as Applied Science Sales Shrink in Q3
October 19, 2010 / In Sequence